Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection.
- Authors:
- AC Ormeci, F Akyuz, B Baran, OM Soyer, S Gokturk, M Onel, D Onel, ...
- Journal:
- European Review for Medical & Pharmacological Sciences 20 (5), 858
- Publication Year:
- 2016
- Citations:
- 29
- Subject Area:
- İnflamatuar Bağırsak Hastalıkları
No verified DOI was found for this publication. The Google Scholar record is shown as the source.
Other Publications in This Subject Area
- Cyclosporine therapy as a rescue treatment in steroid refractory acute severe ulcerative colitis: a real life data from a tertiary center (2022)
- Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy? (2019)
- Belching in irritable bowel syndrome: an impedance study (2017)
- Does the number of mucosal immune cells differ in irritable bowel syndrome and its subtypes? (2017)
- Microscopic colitis in patients with Takayasu's arteritis: a potential association between the two disease entities (2016)
This list was extracted from Prof. Dr. Çetin Karaca's public Google Scholar profile; DOI matches were verified against CrossRef. Citation counts reflect Google Scholar's data at extraction time and are not updated in real time.
← Back to İnflamatuar Bağırsak Hastalıkları publications